Bunker Kevin D.

Chief Scientific Officer | Chief Operating Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

88.2%

Avg 3M Return

+9.6%

Avg 12M Return

+42.9%

Bunker Kevin D. is a Chief Scientific Officer at Zentalis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 35 sells.

Estimated insider holdings value: $3.1M based on current market prices.

Holdings by Company

ZNTLDec 20, 2023

Current Shares834.9K

Value$3.06M

Net Activity-446,005

Bought: 350Sold: 446.4K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 22, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	10,000	$49.09	$490,933.31	-1.5%	-56.6%	-60.5%
Feb 14, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	14,688	$52.47	$770,633.23	-0.5%	-51.2%	-59.9%
Jan 20, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	10,000	$59.99	$599,911.95	-1.8%	-58.1%	-59.5%
Jan 10, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	10,000	$68.41	$684,097.10	-1.3%	-55.6%	-71.3%
Dec 20, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	10,000	$79.24	$792,430.68	-1.2%	-38.4%	-76.1%
Dec 10, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	10,000	$71.71	$717,106.26	-1.2%	-34.4%	-72.7%
Nov 22, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	10,000	$75.99	$759,937.00	-4.3%	-34.0%	-71.3%
Nov 10, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	10,000	$78.15	$781,471.00	-4.2%	-35.1%	-74.1%
Oct 1, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	8,420	$66.13	$556,855.57	-43.2%	+23.2%	-67.7%
Sep 1, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	8,420	$67.49	$568,282.98	-21.8%	+22.3%	-58.5%